{"name":"Vittoria Biotherapeutics","slug":"vittoria-biotherapeutics","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMijwJBVV95cUxOTmJoaHNodUdRTlZJMGRadTJkeGxwdkdiX2xZcmQ3aGZndlFGaGthRFhqdDFCVlNwUUlHRWxCc3NiVU5rWDFwUUg3ZFlHWTlRSFlDUUpfV3hNYUdzT3lfRE5nTjgxX1J1TUw1STVtbU03RDl3TDVBeHI2azdmLW1XUUlFUVg0Rlp1S2pwM01WVTJMT3FMM1Yybk5TY2hvdVE3ejRQYXRhTTBobXR0MnVWZ2Q0VHZWazNTZ3hRZ3VYbWNfR0YybkdhbGZBTGh0TG5sR2dPWG9aRjNEVUdFRFJvNjVGazlqQVBkQWFLQmpUal9PNlA1clZGX1VJb01hUnFHb3l1MHFTc2ZUb05ma2pF?oc=5","date":"2025-11-10","type":"trial","source":"GlobeNewswire","summary":"Vittoria Biotherapeutics Announces Presentation of First-in-Human Interim Phase1 Data for VIPER-101 at ASH2025 - GlobeNewswire","headline":"Vittoria Biotherapeutics Announces Presentation of First-in-Human Interim Phase1 Data for VIPER-101 at ASH2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE5IcnF2SEpHbVBOMzZBdkdTMVhEaUFIYU1NOVliU3dqYl90SHE5TVpIdGY0b0R6bDFwNWFyVzY5cW5SZWkxX1hOQm91ck05X1B0Uy1v?oc=5","date":"2025-10-15","type":"deal","source":"FirstWord Pharma","summary":"Boehringer pens ADC deal with AimedBio worth up to $991M - FirstWord Pharma","headline":"Boehringer pens ADC deal with AimedBio worth up to $991M","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxOM2dCUHVlYjB1UnhkV0h5aVhYWkN3d3VTS2NzTFg4OFFWZEFROFNMWmZBSm1kRnRpZ2VrNXRZY3UwdlZmWGJNdzlyRVU0cWtNRnM0YmJtdkpZQmptZXZPeUVNN3E1aVE1SVlnYVZweWh4eDc5dVhyOVZRQnRuSWYtVDN0bzduRkw3ZXh4ck13Z0pPTUZjTy1PeG9vOEhiRmp5aGV0NHlmdjlCZw?oc=5","date":"2025-10-15","type":"deal","source":"BioSpace","summary":"Boehringer Ingelheim Bets up to Nearly $1B in ADC Play With AimedBio Deal - BioSpace","headline":"Boehringer Ingelheim Bets up to Nearly $1B in ADC Play With AimedBio Deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxNTjFyWC1LTXRPZlVMNmo0aHExWDUxMnlCZDJlSVJCS09qeExzblplcVhFZHR4TDJuei1pRk4xaGFfM2dMbXcwV1djX2c5OVh5ZXd6LXpOenQ3WWtvQ2xSQjIzYVVBRTVTQUxMYkZMT2JaR25jX3dTa1JWc2tEb0p5RTZ0NEtMRklMdjdz?oc=5","date":"2025-02-20","type":"pipeline","source":"BioSpace","summary":"Philadelphia’s Life Sciences Scene Making Its Mark - BioSpace","headline":"Philadelphia’s Life Sciences Scene Making Its Mark","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6AFBVV95cUxOdG5HU0kwZUNwSWpYcl8wQmNEMGg1a2gya0lRN1c5SDFfWDUtZzU0ZTdtUEw2TXI2YzRpMG91NHJuYW9rZF9TUldVaHR1MU5GUkdndDF2THo1SHhna1RXXzJ1UVN2VWdqX1kxeU52dmlQeGJrd3QwZmktV3NYa3pzcjVBSTMtNGNPZU9YdHZyUXJnaFYxdlFtRElHazdzem5KMVZwY3F1WkRCMEd5eTE2b2NFNXZTMHhPT2dzc2pkLVNaYTBEdnF2OFJVbXpGM0d2eDVwSXhYMUxXcVEtT2IzaG9aYWZHLXkz?oc=5","date":"2025-01-06","type":"regulatory","source":"CRISPR Medicine News","summary":"Press Release Service: CAR-T Cell Therapy Market Research 2024-2025: Size, Forecasts, Trials, and Trends - Approved CAR-T Therapies and Late-stage Clinical Trials that Could Reach Commercialization So","headline":"Press Release Service: CAR-T Cell Therapy Market Research 2024-2025: Size, Forecasts, Trials, and Trends - Approved CAR-","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMilgJBVV95cUxPZ2NtejFXZk5DZS1Ydk05OHRQcXJDbVFIN0xocldMMlF4dE9DNnNJMjFaeDloV2Rla0VMWm4xVW53V2VUSlJGYTBxZEJqZjRDUm1lNEM0d0twR2preExHempmU2cyQXdsYWF1SkpENms0bzdiOEpGby1LaFZaLUZTUEpqejBtWDk5YnphM3FTei1JQnpfNEVzNjVZY3hkdUkwdk9xWjZHTDJlMTVnSWY5amNmdk9ta0Nnc2V0X3hXaGhRdXJIbnFwRGZ3Y3k0blU5dE5GTHFvZXlEc0lqQ0JPbUt1ZmI1QXI2VlZ2UXkwZi0tVURxUVZNUGNmUU5pVFJXVGozOFNmMHFKMzV0SXY1Z2VPeTBQdw?oc=5","date":"2024-11-12","type":"pipeline","source":"GlobeNewswire","summary":"Vittoria Biotherapeutics Completes $25 Million in Private Financing to Propel Groundbreaking Cell Therapy Candidates - GlobeNewswire","headline":"Vittoria Biotherapeutics Completes $25 Million in Private Financing to Propel Groundbreaking Cell Therapy Candidates","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiaEFVX3lxTE5TSm00MkRCUEwzY0hKOWxNY1BaS2tIdW9ld19NWGlCby12ZDdsWjVUTzRtVU9LcU9MdlUzYVRPSWJQOEd3cG1yT3F2OV9XbHNhTFk4VWxNaWo4TTNlQmp2aU9Ic3lIZjVM?oc=5","date":"2024-07-22","type":"pipeline","source":"pharmaphorum","summary":"Deep Dive: Oncology 2024 - pharmaphorum","headline":"Deep Dive: Oncology 2024","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxPZDluN1U0SGczQXFWbjctbjRMM19PQm1TWkpyZEs1ZDJ4cDZWaFpDSC1ya2JQM0Jfa0tnMlVOTUhrRndJV3JzRUpiVmF1dUdST1lBYWxFRDlzelFVRWhXa1BuRXdPaUljLXBqN1BrNEVCVjNxaTRvNEoyMVAzY2xjQktMcXNjS0dMMkNRaEVmSzVjVkpZZWduX3ZSMzc?oc=5","date":"2024-07-09","type":"pipeline","source":"pharmaphorum","summary":"Insider insights: Vittoria CEO Nicholas Siciliano on the future of CAR-T - pharmaphorum","headline":"Insider insights: Vittoria CEO Nicholas Siciliano on the future of CAR-T","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxQNHhwOEVtYnMxdmgxbU5iS1lnSHkxTmI3SER2TzNCT0IzR2t0ZXBOR19zbHdST1FPc1cxeTFFMHk2RFdiNEFSSm9mbFpHeXc0YTJ3UFctaEpsTl8yM29ldFJHRkR2WlB5UTNtM3hEa2Nra09PT0taWGNad3JyNjZORWN4bV9MWU5YaGdDZlJ4OWw2eTNUZHFwMGp4WkZGalY4ZUFNNEpWTEJGMVB5b1JUVkJ1S1F4VXZqZTJXZWY4SEk2aE0?oc=5","date":"2024-04-19","type":"trial","source":"Fierce Biotech","summary":"Chutes & Ladders—Recursion makes big executive splash, nabs J&J's chief data science officer - Fierce Biotech","headline":"Chutes & Ladders—Recursion makes big executive splash, nabs J&J's chief data science officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxPelhpNmVDd29ndlhla2otb2NiMGo3LTE1SXNsbVB6NHZsNXdpWVVSTnlTUXV1Mk9RWl83VUttZWN0ekhLY0lxUXZrV0ZDdGkzVUNOcUZ6bElaaWdPSnNJbU03UVBEemo1cUdUZXB2bkhVZVpvQ0tiSjN0a2s0X0VrYjV5SDczcWdVU1Y4LXNCZEJJaE5GLVB5TFFFZjlTenhjdWZpd0dOX2xUb1dC?oc=5","date":"2024-02-27","type":"regulatory","source":"The Pharma Letter","summary":"Vittoria Bio appoints Rosemary Mazanet as chief medical officer - The Pharma Letter","headline":"Vittoria Bio appoints Rosemary Mazanet as chief medical officer","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}